How high-resolution agent-based models can improve fundamental insights in tissue development and cell culturing methods
Paul Van Liedekerke, Jiří Pešek, Kevin Alessandri, Dirk Drasdo
TL;DR
This work surveys high-resolution, physics-driven agent-based modeling for tissue development, focusing on Deformable Cell Models (DCMs) that represent cells as surface-traced shells with explicit cortex mechanics. By contrasting DCMs with SEMs, PFMs, CPMs, and Vertex Models, the authors highlight the trade-offs between geometric fidelity and computational cost, and they outline the force-balance framework that governs node dynamics in DCMs. The paper reviews DCM components, calibration/validation strategies, computational considerations, and software availability, and demonstrates applications to monolayers, spheroids, organoids, micro-carriers, and early embryonic morphogenesis, including lumen and canaliculi formation. The authors argue that DCMs can generate quantitative insights into how subcellular and cortical properties influence tissue-scale structure, with potential for hybrid models and digital-twin workflows, while also calling for standardization and broader access to DCM software to accelerate adoption in biology and biotechnology.
Abstract
The fundamental understanding of how cells physically interact with each other and their environment is key to understanding their organisation in living tissues. Over the past decades several computational methods have been developed to decipher emergent multi-cellular behaviors. In particular agent-based (or cell-based) models that consider the individual cell as basic modeling unit tracked in space and time enjoy increasing interest across scientific communities. In this article we explore a particular class of cell-based models, so-called Deformable Cell Models (DCMs), that allow to simulate the biophysics of the cell with high realism. After situating this model among other model types, We give an overview of past and recent DCM developments and discuss new simulation results of several applications covering in-vitro and in-vivo systems. Our goal is to demonstrate how such models can generate quantitative added value in biological and biotechnological problems.
